These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28545736)

  • 1. Amino-acid sensing and degrading pathways in immune regulation.
    Grohmann U; Mondanelli G; Belladonna ML; Orabona C; Pallotta MT; Iacono A; Puccetti P; Volpi C
    Cytokine Growth Factor Rev; 2017 Jun; 35():37-45. PubMed ID: 28545736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells.
    Mondanelli G; Bianchi R; Pallotta MT; Orabona C; Albini E; Iacono A; Belladonna ML; Vacca C; Fallarino F; Macchiarulo A; Ugel S; Bronte V; Gevi F; Zolla L; Verhaar A; Peppelenbosch M; Mazza EMC; Bicciato S; Laouar Y; Santambrogio L; Puccetti P; Volpi C; Grohmann U
    Immunity; 2017 Feb; 46(2):233-244. PubMed ID: 28214225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid metabolism as drug target in autoimmune diseases.
    Mondanelli G; Iacono A; Carvalho A; Orabona C; Volpi C; Pallotta MT; Matino D; Esposito S; Grohmann U
    Autoimmun Rev; 2019 Apr; 18(4):334-348. PubMed ID: 30797943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
    Bhutia YD; Babu E; Ganapathy V
    Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
    Fallarino F; Grohmann U; Puccetti P
    Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-35Ig-expressing dendritic cells induce tolerance via Arginase 1.
    Panfili E; Mondanelli G; Orabona C; Bianchi R; Gargaro M; Fallarino F; Puccetti P; Grohmann U; Volpi C; Belladonna ML
    J Cell Mol Med; 2019 May; 23(5):3757-3761. PubMed ID: 30793469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of chimeric vaccine stimulation of indoleamine 2,3-dioxygenase biosynthesis in human dendritic cells is independent of TGF-β signaling.
    Esebanmen GE; Langridge WHR
    Cell Immunol; 2017 Sep; 319():43-52. PubMed ID: 28864263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High l-Trp affinity of indoleamine 2,3-dioxygenase 1 is attributed to two residues located in the distal heme pocket.
    Yuasa HJ
    FEBS J; 2016 Oct; 283(19):3651-3661. PubMed ID: 27522067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cancer-specific immune responses by amino acid degrading enzymes.
    Timosenko E; Hadjinicolaou AV; Cerundolo V
    Immunotherapy; 2017 Jan; 9(1):83-97. PubMed ID: 28000524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
    Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO.
    Mondanelli G; Ugel S; Grohmann U; Bronte V
    Curr Opin Pharmacol; 2017 Aug; 35():30-39. PubMed ID: 28554057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases.
    Yuasa HJ; Ball HJ
    J Mol Evol; 2011 Feb; 72(2):160-8. PubMed ID: 21170645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.
    Harden JL; Egilmez NK
    Immunol Invest; 2012; 41(6-7):738-64. PubMed ID: 23017144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of IDO1 and TGF-β1 during recurrence and post infection clearance with Chlamydia trachomatis, are independent of host IFN-γ response.
    Ziklo N; Huston WM; Taing K; Timms P
    BMC Infect Dis; 2019 Mar; 19(1):218. PubMed ID: 30832593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoleamine 2,3-dioxygenases with very low catalytic activity are well conserved across kingdoms: IDOs of Basidiomycota.
    Yuasa HJ; Ball HJ
    Fungal Genet Biol; 2013 Jul; 56():98-106. PubMed ID: 23548750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
    Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
    Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase.
    Orabona C; Pallotta MT; Grohmann U
    Mol Med; 2012 Jul; 18(1):834-42. PubMed ID: 22481272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecules in focus: indoleamine 2,3-dioxygenase.
    King NJ; Thomas SR
    Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evolution of bacterial indoleamine 2,3-dioxygenase.
    Yuasa HJ; Ushigoe A; Ball HJ
    Gene; 2011 Oct; 485(1):22-31. PubMed ID: 21689736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity.
    Liu X; Shin N; Koblish HK; Yang G; Wang Q; Wang K; Leffet L; Hansbury MJ; Thomas B; Rupar M; Waeltz P; Bowman KJ; Polam P; Sparks RB; Yue EW; Li Y; Wynn R; Fridman JS; Burn TC; Combs AP; Newton RC; Scherle PA
    Blood; 2010 Apr; 115(17):3520-30. PubMed ID: 20197554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.